This research falls under the broader scientific discipline of molecular biology and cancer therapeutics, specifically within RNA-guided genome editing and precision oncology. CRISPR-Cas13d systems represent a powerful class of RNA-targeting tools that can precisely edit target transcripts with minimal off-target effects. However, their clinical development faces significant challenges. One of these is the limited biostability of conventional linear guide RNAs (lgRNAs) suscep

Author: Eunice I. Aissi Thesis Supervisor: Tonio Buonassisi Abstract Materials development is the foundation for innovation in many...

Authors: Noah James Langenfeld and Bruce Bugbee Abstract Here we review the 400-year history of hydroponic culture and describe a unique...

Vision-driven Autocharacterization of Perovskite Semiconductors Authors: Alexander E. Siemenn, Eunice Aissi, Fang Sheng, Armi Tiihonen,...

AmbuBox: A Fast-Deployable Low-Cost Ventilator for COVID-19 Emergent Care Authors: Zecong Fang, Andrew I. Li, Hongcheng Wang, Ruoyu...